☰ Menu
  • Accessibility
  • Contact us

Policies and procedures

‹ Return to search

Unlicensed Medicines and Unlicensed Use of Licensed Medicines (Off-Label) Policy (PHA38)


This policy outlines the legal implications, professional responsibilities, monitoring requirements and the procedures to be followed when considering or using either an unlicensed medicine or a licensed medicine off-label.
Date created: 21 March 2017
Last modified: 7 December 2017

Leave feedback